Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 1Rectal Neoplasms 1Pulmonary Embolism 1Neuralgia 1Cancer Pain 1Agnosia 1

Interventions

Dalteparin 10apixaban 9Tinzaparin 4Enoxaparin 4Heparin, Low-Molecular-Weight 3edoxaban 2abelacimab 2Rivaroxaban 2MAA868 2Dabigatran 2perflutren 1isoquercitrin 1enoxaparin sodium 1bemiparin 1Warfarin 1Sulfur Hexafluoride 1Rosuvastatin Calcium 1Hospitals 1Fondaparinux 1Fluorodeoxyglucose F18 1Educational Status 1Deoxyribonucleases 1Acetylcysteine 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pulmonary Embolism × Hospitals × Clear all
NCT04158973 2021-08-03

CHIPs-VTE Study in Hospitalized Patients With Lung Cancer

China-Japan Friendship Hospital

Phase NA Unknown
3,200 enrolled

Pulmonary Embolism, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡